{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T02:09:09Z","timestamp":1763172549222,"version":"3.45.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03381-x","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:42:46Z","timestamp":1763138566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum soluble transferrin receptor (sTfR) in HFpEF: associations with cardiac function and exercise tolerance"],"prefix":"10.1186","volume":"30","author":[{"given":"Jianfei","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"6","key":"3381_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s11897-022-00578-7","volume":"19","author":"M Eltelbany","year":"2022","unstructured":"Eltelbany M, Shah P, Defilippi C. Biomarkers in HFpEF for diagnosis, prognosis, and biological phenotyping. Curr Heart Fail Rep. 2022;19(6):412\u201324.","journal-title":"Curr Heart Fail Rep"},{"key":"3381_CR2","first-page":"119","volume":"21","author":"M Gori","year":"2020","unstructured":"Gori M, D\u2019Elia E, Zambelli G, Senni M. Heart failure with preserved ejection fraction: an update on diagnosis and treatment. G Ital Cardiol (Rome). 2020;21:119\u201327.","journal-title":"G Ital Cardiol (Rome)"},{"issue":"9","key":"3381_CR3","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2174\/1389450119666180605112235","volume":"19","author":"M Kobayashi","year":"2018","unstructured":"Kobayashi M, Suhara T, Baba Y, et al. Pathological roles of iron in cardiovascular disease. Curr Drug Targets. 2018;19(9):1068.","journal-title":"Curr Drug Targets"},{"key":"3381_CR4","doi-asserted-by":"crossref","unstructured":"Sierpinski R, Josiak K, Suchocki T.et al. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality. Eur J Heart Fail. 2021; 23: 919\u2013932, Erratum in Eur J Heart Fail 2022; 24: 591.","DOI":"10.1002\/ejhf.2383"},{"issue":"8","key":"3381_CR5","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.cardfail.2021.12.018","volume":"28","author":"S Fitzsimons","year":"2022","unstructured":"Fitzsimons S, Poppe KK, Choi Y. Relationship between soluble transferrin receptor and clinical outcomes in patients with heart failure according to ejection fraction phenotype: the New Zealand PEOPLE study. J Card Fail. 2022;28(8):1255\u201363.","journal-title":"J Card Fail"},{"issue":"11","key":"3381_CR6","doi-asserted-by":"publisher","first-page":"1469730","DOI":"10.3389\/fcvm.2024.1469730","volume":"14","author":"Y Yang","year":"2025","unstructured":"Yang Y, Lv X, Tan K, et al. The correlation between serum MHR and NLR and the severity of coronary lesions in NSTE-ACS patients of different genders. Front Cardiovasc Med. 2025;14(11):1469730.","journal-title":"Front Cardiovasc Med"},{"issue":"36","key":"3381_CR7","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA Mcdonagh","year":"2021","unstructured":"Mcdonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"issue":"1","key":"3381_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jcu.23572","volume":"52","author":"YE Yavuz","year":"2024","unstructured":"Yavuz YE, Soylu A, G\u00fcrb\u00fcz AS. The relationship of systemic and pulmonary arterial parameters with HFpEF scores (H2 FPEF, HFA-PEFF) and diastolic dysfunction parameters in heart failure patients with preserved ejection fraction. J Clin Ultrasound. 2024;52(1):39\u201350.","journal-title":"J Clin Ultrasound"},{"issue":"11","key":"3381_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","volume":"124","author":"MA Pfeffer","year":"2019","unstructured":"Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124(11):1598\u2013617.","journal-title":"Circ Res"},{"issue":"18","key":"3381_CR10","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","volume":"81","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Sharma K, Shah SJ, et al. Heart failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol. 2023;81(18):1810\u201334.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"3381_CR11","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the american College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263\u2013421.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"3381_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","volume":"108","author":"DF Dai","year":"2011","unstructured":"Dai DF, Johnson SC, Villarin JJ, et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res. 2011;108(7):837\u201346.","journal-title":"Circ Res"},{"issue":"10","key":"3381_CR13","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jacc.2018.06.050","volume":"72","author":"T Jasper","year":"2018","unstructured":"Jasper T, Daan WB, Wouter O, et al. Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2018;72(10):1081\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3381_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.31053\/1853.0605.v82.n1.44359","volume":"82","author":"MT Politi","year":"2025","unstructured":"Politi MT, Daquarti GJ, Spagnuolo DN, et al. Anemia e insuficiencia card\u00edaca con fracci\u00f3n de eyecci\u00f3n conservada en pacientes adultos con s\u00edndrome cardiorrenal [Anemia and heart failure with preserved ejection fraction in adult patients with cardiorenal syndrome: a cross-sectional study]. Rev Fac Cien Med Univ Nac Cordoba. 2025;82(1):22\u201340.","journal-title":"Rev Fac Cien Med Univ Nac Cordoba"},{"key":"3381_CR15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.5551\/jat.RV17009","volume":"24","author":"H Abe","year":"2017","unstructured":"Abe H, Semba H, Takeda N. The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb. 2017;24:884\u201394.","journal-title":"J Atheroscler Thromb"},{"issue":"10","key":"3381_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.874846","volume":"12","author":"S Zhu","year":"2022","unstructured":"Zhu S, Liu C, Zhao C, et al. Increased serum soluble transferrin receptor levels were associated with high prevalence of cardiovascular diseases: insights from the national health and nutrition examination survey 2017\u20132018. Front Cell Dev Biol. 2022;12(10):874846.","journal-title":"Front Cell Dev Biol"},{"key":"3381_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.beem.2015.09.003","volume":"29","author":"K Harms","year":"2015","unstructured":"Harms K, Kaiser T. Beyond soluble transferrin receptor: old challenges and new horizons. Best Pract Res Clin Endocrinol Metab. 2015;29:799\u2013810.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"3381_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2011.08.006","volume":"159","author":"P Leszek","year":"2012","unstructured":"Leszek P, Sochanowicz B, Szperl M, et al. Myocardial iron homeostasis in advanced chronic heart failure patients. Int J Cardiol. 2012;159(1):47\u201352.","journal-title":"Int J Cardiol"},{"key":"3381_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","volume":"119","author":"SA Dick","year":"2016","unstructured":"Dick SA, Epelman S. Chronic heart failure and inflammation: what do we really know? Circ Res. 2016;119:159\u201376.","journal-title":"Circ Res"},{"issue":"1","key":"3381_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-020-01242-6","volume":"19","author":"DLE Villanueva","year":"2020","unstructured":"Villanueva DLE, Tiongson MD, Ramos JD, et al. Monocyte to high-density lipoprotein ratio (MHR) as a predictor of mortality and major adverse cardiovascular events (MACE) among ST elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis. Lipids Health Dis. 2020;19(1):55.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"3381_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.cyto.2007.05.015","volume":"38","author":"M Fritzenwanger","year":"2007","unstructured":"Fritzenwanger M, Meusel K, Foerster M, et al. Cardiotrophin-1inducesinterleukin-6synthesisinhuman monocytes. Cytokine. 2007;38(3):137\u201344.","journal-title":"Cytokine"},{"issue":"1","key":"3381_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s40001-023-01451-6","volume":"28","author":"Q Li","year":"2023","unstructured":"Li Q, Lin X, Bo X, et al. Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study. Eur J Med Res. 2023;28(1):493.","journal-title":"Eur J Med Res"},{"issue":"1","key":"3381_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","volume":"4","author":"D Westermann","year":"2011","unstructured":"Westermann D, Lindner D, Kasner M, et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail. 2011;4(1):44\u201352.","journal-title":"Circ Heart Fail"},{"issue":"3","key":"3381_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1536\/ihj.21-681","volume":"63","author":"J Zhong","year":"2022","unstructured":"Zhong J, Huang Z, Tang X, et al. Monocyte to high-density lipoprotein cholesterol ratio is associated with subclinical left cardiac remodeling and dysfunction in type 2 diabetes mellitus. Int Heart J. 2022;63(3):524\u201330.","journal-title":"Int Heart J"},{"key":"3381_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041199","volume":"9","author":"A Alcaide-Aldeano","year":"2020","unstructured":"Alcaide-Aldeano A, Garay A, Alcoberro L, Jim\u00e9nez-Marrero S, et al. Iron deficiency: impact on functional capacity and quality of life in heart failure with preserved ejection fraction. J Clin Med. 2020;9:1199.","journal-title":"J Clin Med"},{"issue":"16","key":"3381_CR26","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.3390\/jcm13164742","volume":"13","author":"R Ramos-Polo","year":"2024","unstructured":"Ramos-Polo R, Ras-Jim\u00e9nez MDM, Francesch Manzano J, et al. Prognostic role of tissue iron deficiency measured by sTfR levels in heart failure patients without systemic iron deficiency or anemia. J Clin Med. 2024;13(16):4742.","journal-title":"J Clin Med"},{"issue":"6","key":"3381_CR27","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.3390\/ijms24065645","volume":"24","author":"S Dhaliwal","year":"2023","unstructured":"Dhaliwal S, Kalogeropoulos AP. Markers of iron metabolism and outcomes in patients with heart failure: a systematic review. Int J Mol Sci. 2023;24(6):5645.","journal-title":"Int J Mol Sci"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03381-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03381-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03381-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T02:04:33Z","timestamp":1763172273000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03381-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3381"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03381-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"type":"electronic","value":"2047-783X"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"1127"}}